NutraLec®
Lectin Labs' technology has been validated by human clinical trials for its initial product, NutraLec, which was launched in 2003. NutraLec is a functional nutraceutical and is based on a particular lectin found in wheat grain. The Company has determined that this lectin acts to neutralize a widespread and potentially deadly pathogen found in the stomach, Helicobacter pylori. This microorganism is responsible for a variety of gastric ailments, including gastritis, ulcers, and stomach cancer (the second leading cause of cancer deaths). Until now, the only available treatment has been antibiotic regimens which frequently fail because of antibiotic-resistant strains of H. pylori. Human trials have shown that NutraLec safely and effectively brings this infectious microbe under control.

NutraLec is currently being positioned as a functional nutraceutical.

For further details about NutraLec® click here.

Lectin Labs is also concentrating its research and development on four other innovative products: PhytoCAM VM, PhytoCAM Condom, PhytoCAM Ulcer, and Ultra-Pure Lectins™.

PhytoCAM VM
Public health officials are emphasizing the need for a vaginal microbicide; women do not currently have a product to discreetly defend against STDs, and infection rates are soaring. Toward that end, Lectin Labs is developing a topical cream that can bind with and destroy the infectious qualities of certain major STDs, including HIV/AIDS.
 

PhytoCAM Condom
It has been recently discovered that latex condoms can leak and allow the passage of viruses, including certain microbes associated with STDs. Research has shown that any leakage containing infected male ejaculate or infected vaginal fluid can be neutralized by a lectin-containing surface coating on the condom. Lectin Labs will develop and manufacture the coating formulation, while the condom manufacturer will apply the coating and handle distribution and marketing. This innovative condom will bind to the pathogens associated with HIV/AIDS, gonorrhea, and chlamydia, and reduce the risk of infection should a condom leak.
 

PhytoCAM Ulcer
H. pylori is the principal agent causing gastritis, ulcers and stomach cancer. It's believed that two-thirds of the world's population has been infected by these bacteria, including 50-percent of all U.S. residents. Lectin Labs is developing a potent pharmaceutical-grade variant of the lectin found in NutraLec. This Rx product will be administered orally in capsule or pill form.
 

Ultra-Pure Lectins
Lectins have been of longstanding interest to the research community. This curiosity has prompted scientists to perform various clinical diagnostic tests using lectins. It has also helped them identify cellular carbohydrate structures, and map the surface of many kinds of cells found in biology. Other clinical research continues to focus on the use of lectins as injectables to treat AIDS and cancer patients. All of this has created a growing market for production of certain lectins which would be manufactured in very small quantities (milligrams) and command premium prices. While there are a handful of other specialized suppliers of lectins in the world, their supply is generally limited and impure. Lectin Labs enters this market with the know-how to manufacture unique and highly purified products.
 

Other Product Opportunities
Lectin Labs has already identified numerous additional opportunities for its lectin technology, including: DermaLec™ products (acne treatment, control of body odor); medications for periodontal disease (for which there is no satisfactory treatment regimen); and topical treatment for other diseases of the gastrointestinal tract (C. difficile antibiotic-associated colitis and other diarrheal diseases caused by E. coli and Giardia). Certain lectin formulations may also be targeted to agricultural and animal diseases.

[return to top]